Experiment 1121319

Worktypes

PHARMACOLOGY OF EXTRACT - IN HUMANSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.EFFECTS DESCRIBED ARE FROM A MULTI-COMPONENT RX.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTISCHISTOSOMAL ACTIVITY
Administration routeEXTERNAL
OrganismAlpinia officinarum (ZINGIBERACEAE)
CitationCOLLINS,KR:. (1981). PHARMACEUTICAL COMPOSITION.. ()
Amount utilized
Compound isolated
DiseaseTHE PRODUCT USED CONTAINS SANGUINARIA CANADENSIS,ALPINIA OFFICINARUM AND ZINC CHLORIDE. IT IS CLAIMED TO BE USEFUL FOR SKIN CANCER,CARIES AND PERIODONTAL DISEASES,BILHARZIASIS AND PSEUDOMONAS AERUGINOSA INFECTIONS OF THE SKIN A PASTE IS APPLIED TO THE GINGIVA AND TEETH OF PATIENTS WITH PERIODONTAL DISEASE FOR CA. 10 MINUTES,FOLLOWED BY RINSING. THE TREATMENT IS REPEATED 1-4 TIMES AT 2-7 DAY INTERVALS.
Number3
Qualitative result.
AnimalHUMAN ADULT
Dose expressionCONC USED
ExtractMEOH EXT